Buys
Open market- Shares
- Avg price
- Total value
Matthew B. Klein - CHIEF EXECUTIVE OFFICER, Director at PTC THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- PTCT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Matthew B. Klein in PTC THERAPEUTICS, INC.
Sells
Open market- Shares
- -57,943
- Avg price
- $72.83
- Total value
- -$4,219,886
Net
Past year- Shares
- -57,943
- Share %
- -100%
- Total value
- -$4,219,886
Reported holdings for Matthew B. Klein in PTC THERAPEUTICS, INC.
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
PTC THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 383,868
- Estimated value
- $26,321,828
- Report date
- 04 Aug 2026
- Price
- $68.57
- Ownership
- Direct
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
PTC THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 157,500
- Estimated value
- $4,733,750
- Report date
- 02 Jan 2026
- Price
- $27.05
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Matthew B. Klein in PTC THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.